Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

0
30



The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here